[Primary sclerosing cholangitis. To slow progression and reduce carcinoma risk].
D000328:Adult; D002756:Cholagogues and Choleretics / Q000008:administration & dosage / Q000627:therapeutic use*; D015209:Cholangitis, Sclerosing / Q000150:complications / Q000188:drug therapy*; D003110:Colonic Neoplasms / Q000517:prevention & control; D015179:Colorectal Neoplasms / Q000517:prevention & control; D006801:Humans; D010919:Placebos; D016032:Randomized Controlled Trials as Topic; D012189:Retrospective Studies; D012307:Risk Factors; D013607:Tablets; D013997:Time Factors; D014580:Ursodeoxycholic Acid / Q000008:administration & dosage / Q000627:therapeutic use*
D002756:Cholagogues and Choleretics; D010919:Placebos; D013607:Tablets; D014580:Ursodeoxycholic Acid